Study suggests miR-377 as potential therapeutic target for prostate cancer

FHS
May 22, 2024
7:10 pm

A new research paper was published in Genes & Cancer on May 16, 2024, entitled, “Inhibitory effect of miR-377 on the proliferative and invasive behaviors of prostate cancer cells through the modulation of MYC mRNA via its interaction with BCL-2/Bax, PTEN, and CDK4.”

Evotec-partner Jingxin receives approval for EVT201 in China – Biotech Investments

EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec-partner Jingxin receives approval for EVT201 in China 06.12.2023 / 07:30 CET/CEST The issuer is solely responsible for

December 7, 2023

One Size Doesn’t Fit All for Automated BP Measurement Cuffs, Trial Finds

Using a “regular” size arm cuff with an automated blood pressure (BP) device for all adults resulted in inaccurate BP readings regardless of arm size,

August 8, 2023

New study challenges dopamine’s role in placebo effects and pain relief

New findings argue against a direct causal role for dopamine during the experience of a treatment effect in the establishment of positive treatment expectations and

September 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.